glp-1 obesity drug news october 21 2025 Market New weight-loss drugs surge in
Description
R., Fritsche, A., Gribble, F., Grill, H
That does not mean every meal has to be huge or complicated
Cardiovascular and kidney benefits of SGLT-2is and GLP-1RAs according to baseline blood pressure in type 2 diabetes: a systematic meta-analysis of cardiovascular outcome trials
Pooled analysis including these two studies in addition to SELECT and FLOW [31] reported that semaglutide reduced the risk of hospitalization or urgent visits due to heart failure by 41% (HR 0.59, 95% CI 0.410.82) in HFpEF patients compared with placebo [32]
Ventral frontal satiation-mediated responses to food aromas in obese and normal-weight women
Some patients notice improvements in morning stiffness and pain levels as early as weeks 3 to 4
